Jesse Singal: Should Kids Medically Transition?

Should kids medically transition between genders?Show more

The number of kids diagnosed with gender dysphoria has surged in recent years. In America, diagnoses have almost tripled from about 15,000 to more than 42,000 from 2017 to 2021. In the United Kingdom, the number of minors referred to the national Gender Identity Development Service grew from 51 in 2009 to 1,766 by 2016, leading to yearslong waitlists for care within the government-run health system.

This surge caused England's National Health Service to commission an extensive study of youth gender treatment. That study is known as the Cass Review, and its results dropped on April 10. The review's author, former head of the Royal College of Paediatrics and Child Health Hilary Cass, concluded that modern youth gender dysphoria interventions are informed by "remarkably weak evidence" drawing on studies "exaggerated by people on all sides of the debate to support their viewpoint" and that "we have no good evidence on the long-term outcomes of interventions to manage gender-related distress." The science, it turns out, is not settled—or anywhere close to it.

NHS England opted to stop routine prescriptions of puberty blockers following the review's publication, as have NHS Scotland and the Welsh government. Major American medical groups such as the American Psychiatric Association, American Medical Association, and American Academy of Pediatrics, all of which endorse prescribing puberty blockers for gender-dysphoric kids, have yet to officially respond.

American media coverage of the Cass Review, which could throw the entire youth gender treatment paradigm in this country into question, has been remarkably muted. But today's guest is never muted. Jesse Singal has been covering this topic—and taken a lot of heat for it—for years in the pages of publications such as The Atlantic, The Dispatch, and on his Substack, Singal-Minded.

Watch the full conversation on Reason's YouTube channel or the Just Asking Questions podcast feed on Apple, Spotify, or your preferred podcatcher.